• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
cnb1439_3rs-project_nav-ad_v2
  • About us
  • News
  • Events
  • Careers
cn-bio-organ-on-a-chip-logo
  • Products
    • PhysioMimix® OOC Microphysiological Systems
    • Consumables
      • PhysioMimix® Multi-chip plates
      • 3D validated cells
      • NASH-in-a-box
    • Organ-on-a-chip models
    • Gut/Liver-on-a-chip
    • Lung-on-a-chip
    • Support packages
  • Applications
    • Disease modeling
    • Safety toxicology
    • ADME
  • Services
    • Non-Alcoholic Steatohepatitis
    • Drug-Induced Liver Injury
    • ADME
  • Technology
  • Resources
  • Company
    • About us
    • Events
    • News
    • Careers in Biotech
  • Contact us

Explore our solutions


PhysioMimix® is a suite of hardware, consumables and assay protocols that enable you to recreate complex human biology and accurately predict human drug responses.

PhysioMimix OOC

physiomimix-single-and-multi-organ-on-a-chip-systems
Learn more

Consumables

Multi-chip plates
3D validated cells
NASH-in-a-box
Bioavailability assay kit: Human 18
DILI assay kit: Human 24
Learn more

Models

Single-organ models
- Liver-on-a-chip model
- Lung-on-a-chip model
Multi-organ models
- Gut/Liver-on-a-chip models

Support packages

PhysioMimix® support packages

Discover the applications


Investigate the application areas that our PhysioMimix® products and services support

Learn more

Disease modeling

Metabolic dysfunction-associated steatohepatitis
Hepatitis B
Pulmonary infection
Learn more

Safety toxicology

Drug-induced liver injury
Immune-mediated liver injury
Learn more

ADME

Drug absorption
Drug metabolism
Drug bioavailability
Oligonucleotide delivery
Learn more

Studies as a service


Our team will work collaboratively with you to design a study around your research goals and generate actionable data within weeks

Learn more
icon-nash-1-150x150.png MASLD/MASH
icon-dili-tox-150x150.png Drug-induced liver injury
icon-adme-150x150.png ADME

Meet the CN Bio team – Oliver Culley

November 18, 2024

Welcome back to our “Meet the CN Bio team” blog series, where we are showcasing the unique expertise and talent that makes us who we are.

We caught up with Senior Scientist, Oliver Culley…

cnb1236 meet the team blog oliver v1 | CN Bio team

1. How long have you been at CN Bio? What were your first impressions?

I joined CN Bio in November 2023, having worked as a research scientist for more than 10 years in both academia and industry. I was warmly welcomed into the company by every member of the team. It was clear right from the beginning how passionate and kind my new colleagues were. Looking forward, I am keen to help achieve CN Bio’s ambitious goals for the year ahead.

2. Describe your role at the company

As a Senior Scientist in the R&D team, I am responsible for furthering our contributions in the NAFLD/NASH research field. My day-to-day involves the effective management of several projects, as well as supervising junior team members, and collaborating with others in the business to ensure CN Bio remains competitive, innovative, and able to fulfill customer needs.

3. What is the most interesting aspect of your job?

As a part of the R&D team, there is great scope to elevate CN Bio’s products and solutions to reach new heights that align with the current and emerging needs of an evolving industry. I enjoy the freedom to learn and develop each day. I am excited to see how the work we do in R&D impacts marketing, production, and other areas of the business to ultimately help our customers fulfill their goals.

4. How does the company support employees in achieving a good work-life balance?

As a father of two young boys (3 years and 10 months), it is important to me that I can progress in my career and be there for my family at the same time. CN Bio allows me to do just this. With a recognition culture, and clear and kind leadership, I know that the team around me values not only my work output but also my health, and the well-being of my family. This provides the right environment for each employee and team to succeed.

5. How does the company support employees in achieving their career goals?

CN Bio’s targets and opportunities are described clearly through regular one-to-one, team-centric, and company-wide meetings. I am able to discuss my responsibilities, challenges, career goals, and ambitions through appraisals and catch-ups with my line manager. I am offered flexibility and independence with my workload, which makes me feel trusted and valued; and allows me to develop as a scientist.

6. Do you feel like you have a voice in the company?

Despite having only been at CN Bio for a short time I feel heard, and that my opinion is important. I have been actively encouraged to give feedback and feel safe to do so. In my experience, this is not always the culture in businesses. You cannot simply talk into existence a ‘speak-up’ culture, it comes through mutual trust across the organization.

Category iconTeam Q&A

Primary Sidebar

Other recent news

  • CN Bio adds computational modelling capabilities to ADME services for enhanced bioavailability profiling September 1, 2025
  • Integrating In Silico Tools with Organ-on-a-Chip to advance ADME studies July 15, 2025
  • NIH to prioritize human-based research technologies & reduce animal use in research July 7, 2025
  • CN Bio to participate in 3Rs Collaborative-led project with FDA to build confidence in Liver MPS for DILI June 25, 2025
  • CN Bio introduces cross-species DILI services to enhance in vitro to in vivo extrapolation during preclinical drug development June 10, 2025

Speak to our experts

Request a meeting with one of our OOC experts to see how our products and services can support your studies

Request a meeting

Footer

CN Bio logo

332 Cambridge Science Park, Milton Road
Cambridge, CB4 0WN

UK: +44 (0) 1223 737 941

US: +1 415 523 4005

Privacy | Cookies | Regulatory | Accessibility
Website terms | Terms of sale

Product Recycling

©2025 CN Bio Innovations Ltd
Registered No. ‍06517359. VAT No. GB978184563

Latest news

  • CN Bio adds computational modelling capabilities to ADME services for enhanced bioavailability profiling September 1, 2025
  • Integrating In Silico Tools with Organ-on-a-Chip to advance ADME studies July 15, 2025
  • NIH to prioritize human-based research technologies & reduce animal use in research July 7, 2025
Cyber Essentials Logo